Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma
| Image |  |
|---|---|
| Description | scientific article published on November 13, 2013 |
| Author/s | |
| Publication date | November 13, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |